Position
Fidelity in Nurix Therapeutics, Inc.
Back to the book · All holders of NRIX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $48.1M$15.50 → $24.26
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 4.23M | $80.3M | — | — | — | 0.0% |
| Q1 2026 | 5.54M | $85.9M | $15.50 | −$14.7M | $20.3M | 0.0% |
| Q2 2026 | 5.49M | $133.1M | $24.26 | $48.1M | −$868.9K | 0.0% |